StockClub

INO

INOInovio Pharmaceuticals, Inc.$ --
Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

INO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -100.0%
Operating Income
-22M USD
YoY +12.4%
Net Income
-20M USD
YoY +0.1%
EPS
-0.28$
YoY +45.1%

Revenue

$0
FY2024 Q2$100,762
$100,762
Q2
FY2024 Q3$100,762
$100,762
Q3
FY2024 Q4$217,756
$217,756
Q4
FY2025 Q1$65,343
$65,343
Q1
FY2025 Q2$65,343
$65,343
Q2
FY2025 Q3$65,343
$65,343
Q3
FY2025 Q4$65,343
$65,343
Q4
FY2026 Q1$0
$0
Q1
Actual
$-65,343 (-100.0%)

Net Income

$-19.7M
FY2024 Q2$-62.7M
$-62.7M
Q2
FY2024 Q3$-87.9M
$-87.9M
Q3
FY2024 Q4$-107.3M
$-107.3M
Q4
FY2025 Q1$-19.7M
$-19.7M
Q1
FY2025 Q2$-43.2M
$-43.2M
Q2
FY2025 Q3$-88.7M
$-88.7M
Q3
FY2025 Q4$-84.9M
$-84.9M
Q4
FY2026 Q1$-19.7M
$-19.7M
Q1
Actual
+$11,899 (+0.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$7.4M
Est:$3.2M
FY2020BEAT
$7.4M
FY2021MISS
Actual:$1.8M
Est:$3.3M
FY2021MISS
$1.8M
FY2022MISS
Actual:$10.3M
Est:$10.6M
FY2022MISS
$10.3M
FY2023BEAT
Actual:$832,010
Est:$717,067
FY2023BEAT
$832,010
FY2024BEAT
Actual:$217,756
Est:$133,467
FY2024BEAT
$217,756
FY2025MISS
Actual:$65,343
Est:$86,000
FY2025MISS
$65,343

Analyst Estimates